Attached files

file filename
10-K - FORM 10-K - Xtant Medical Holdings, Inc.tv488883_10k.htm
EX-32.1 - EXHIBIT 32.1 - Xtant Medical Holdings, Inc.tv488883_ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - Xtant Medical Holdings, Inc.tv488883_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - Xtant Medical Holdings, Inc.tv488883_ex31-1.htm
EX-23.1 - EXHIBIT 23.1 - Xtant Medical Holdings, Inc.tv488883_ex23-1.htm


Exhibit 32.2


Section 1350 Certification of Chief Financial Officer


In connection with the Annual Report on Form 10-K of Xtant Medical Holdings, Inc. (the "Company") for the annual period ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Laura Kendall, Deputy Restructuring Officer of the Company, certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:


  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and


  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Laura Kendall  
Laura Kendall  

Deputy Restructuring Officer

(serving as principal financial officer)

April 2, 2018